Anika Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Anika Therapeutics's estimated annual revenue is currently $144.7M per year.
- Anika Therapeutics's estimated revenue per employee is $317,237
- Anika Therapeutics's total funding is $18.5M.
- Anika Therapeutics's current valuation is $493.9M. (January 2022)
Employee Data
- Anika Therapeutics has 456 Employees.
- Anika Therapeutics grew their employee count by 2% last year.
Anika Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and President | Reveal Email/Phone |
2 | VP Sales and Marketing, Americas | Reveal Email/Phone |
3 | SVP International Sales and Marketing | Reveal Email/Phone |
4 | VP Regulatory Affairs, Quality, and Clinical Affairs | Reveal Email/Phone |
5 | EVP, General Counsel and Corporate Secretary | Reveal Email/Phone |
6 | VP Sales and Marketing, Americas | Reveal Email/Phone |
7 | Executive Director, Regulatory Affairs | Reveal Email/Phone |
8 | Process Development Manager | Reveal Email/Phone |
9 | Manufacturing Manager | Reveal Email/Phone |
10 | Senior Health, Safety, and Environment Manager | Reveal Email/Phone |
Anika Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Anika Therapeutics?
Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. In addition to ORTHOVISC(R), a treatment for osteoarthritis of the knee (not approved for sale in the U.S.), Anika markets HYVISC(R) in the U.S. for the treatment of equine osteoarthritis through Boehringer Ingelheim Vetmedica, Inc. and manufactures AMVISC(R) and AMVISC(R) Plus, HA viscoelastic products for ophthalmic surgery, for Bausch & Lomb. It also produces STAARVISCTM-II for distribution by STAAR Surgical Company, Shellgel(TM) for Cytosol Ophthalmics, Inc., and CoEase(TM) for Allergan, Inc.
keywords:N/A
$18.5M
Total Funding
456
Number of Employees
$144.7M
Revenue (est)
2%
Employee Growth %
$493.9M
Valuation
N/A
Accelerator
Anika Therapeutics News
Allergan, Inc. Anika Therapeutics; F. Hoffmann-La Roche AG; Ferring Pharmaceuticals Co; Galderma S.A.; Salix Pharmaceuticals Inc. Sanofi AG; Seikagaku...
The report identifies Acumed LLC, Anika Therapeutics Inc., Extremity Medical LLC, Integra LifeSciences Corp., and Johnson and Johnson as some of...
This table compares Silk Road Medical and Anika Therapeutics' revenue, earnings per share (EPS) and valuation. Gross Revenue, Price/Sales Ratio...
Other Companies in Bedford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $158.3M | 469 | 6% | N/A |
#2 | $75.6M | 488 | 8% | N/A |
#3 | $167.1M | 495 | -2% | N/A |
#4 | $168.4M | 499 | 10% | N/A |
#5 | $139.2M | 506 | 5% | N/A |